Jeff Fairman Vaxcyte, Inc. (PCVX) insider trading activity

PCVX Quotes by TradingView

Jeff Fairman is VP, Research of Vaxcyte, Inc.. Currently has a direct ownership of 17,143 shares of PCVX, which is worth approximately $1.91 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 4,750 shares (Common Stock) at a price of $0.04 per share, resulting in proceeds of $190. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
0% 3M change
0% 12M change
Total Value Held $1.91 Million

Jeff Fairman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2021
BUY
Exercise of conversion of derivative security
$190 $0.04 p/Share
4,750 Added 43.55%
6,158 Common Stock
Jan 26 2021
SELL
Open market or private sale
$121,457 $25.57 p/Share
4,750 Reduced 77.14%
1,408 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$190 $0.04 p/Share
4,750 Added 43.55%
6,158 Common Stock
Dec 29 2020
BUY
Exercise of conversion of derivative security
$1,325 $1.79 p/Share
740 Added 34.45%
1,408 Common Stock
JF

Jeff Fairman

VP, Research
San Carlos, CA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCVX